Author:
Zhao Shijia,Zhang Xiaoyan,Tang Min,Liu Xiaocheng,Deng Jialun,Zhou Wei,Xu Zhi
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics
Reference24 articles.
1. Hong R, Xu B. Breast cancer: an up-to-date review and future perspectives. Cancer Commun. 2022;42:913–36.
2. Garreffa E, Arora D. Breast cancer in the elderly, in men and during pregnancy. Surg (U Kingd). 2022;40:139–46.
3. Ameri A, Tavakoli-Far B, Rostami M, Abedi-Kiasari B, Sakhaei D, Ahmed OS, et al. Recent advances in atezolizumab-based programmed death-ligand 1 (PD-L1) blockade therapy for breast cancer. Int Immunopharmcol. 2022;113:e109334.
4. Morgan J, Fullerton R, Bedi C. Treatment of locally recurrent and advanced breast cancer. Surg (U Kingd). 2022;40:147–51.
5. Zhang L, Zhou X, Sha H, Xie L, Liu B. Recent progress on therapeutic vaccines for breast cancer. Front Oncol. 2022;12:e905832.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献